| Active Ingredient | CIPROFLOXACIN |
| Therapeutic Class | QUINOLONES |
| Indications |
Ciprofloxacin is effective in a variety of infections due to gram- positive and gram-negative pathogens, including multi-resistant strains. It is also indicated for us in individuals exposed to inha More ... |
| Caution | Gastrointestinal disturbances; CNS side effects, including seizures. Increases in transaminases and in some cases severe and fatal hepatitis have developed. Hematuria and anaphylactic reactions have More ... |
| Dose Range | Adult: 250-750mg twice daily, depending on the severity of the infection. Inhalational post-exposure anthrax: 500mg every 12 hours. Pediatric: inhalational p ost-exposure anthrax: 10mg/kg every 12 hours. Maximum 400mg daily. See BDS supply protocols |
| Drug Interactions | |
| Pregnancy | Avoid in pregnancy—shown to cause arthropathy in animal studies; safer alternati More ... |
| Breast Feeding | Amount too small to be harmful but manufacturer advises avoid. |
| Active Ingredient | LEVOFLOXACIN |
| Therapeutic Class | QUINOLONES |
| Indications | Community -acquired pneumonia, urinary -tract infections, chronic prostatitis, complicated skin and soft tissue infections. |
| Caution | Constipation; flatulence (in adults); hyperhidrosis (in adults). The drug should be discontinued if psychiatric, neurological, or hypersensitivity reactions (including severe rash) occur. |
| Dose Range | Adult: 250 to 500 mg once or twice daily for 7 to 14 days depending on the severity and nature of the infection. Chronic prostatitis: 500mg once daily for 28 days. |
| Drug Interactions | |
| Pregnancy | Avoid in pregnancy—shown to cause arthropathy in animal studies; safer alternati More ... |
| Breast Feeding | Manufacturer advises use only if potential benefit outweighs risk. |
| Active Ingredient | OFLOXACIN |
| Therapeutic Class | QUINOLONES |
| Indications | Uncomplicated gonorrhea, nongonococcal urethritis, acute pelvic inflammatory disease, acute uncomplicated cystitis, complicated urinary tract infections,chronic bacterial prostatitis. |
| Caution | Nausea, insomnia, headache, dizziness, diarrhea, vomiting, rash, and pruritus. The safety and efficacy of ofloxacin in pediatric patients and adolescents (under age 18 years), and pregnant and lactati More ... |
| Dose Range | 200mg-400mg twice daily. A single oral dose of 400mg is indicated for uncomplicated gonorrhea. See BDS supply protocols pg. 3. |
| Drug Interactions | |
| Pregnancy | Avoid in pregnancy—shown to cause arthropathy in animal studies; safer alternati More ... |
| Breast Feeding | Amount probably too small to be harmful but manufacturer advises avoid |
| Active Ingredient | CIPROFLOXACIN |
| Therapeutic Class | EENT ANTIBACTERIALS |
| Indications | Corneal ulcer, superficial bacterial infections caused by susceptible strains. |
| Caution |
Corneal deposits (reversible after completion of treatment); ocular discomfort; ocular hyperaemia; taste disturbance. Local discomfort, pain, or pruritus have occurred after use of ear drops. |
| Dose Range |
Drop: 4 times a day, Ointment: 1.25 centimetres 3 times a day for 2 days, then apply 1.25 centimetres twice daily for 5 days. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | OFLOXACIN |
| Therapeutic Class | EENT ANTIBACTERIALS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CIPROFLOXACIN | DEXAMETHASONE |
| Therapeutic Class | ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS |
| Indications | Infected eye disorders. Must be prescribed by an ophthalmologist. |
| Caution | As for ciprofloxacin, contains a corticosteroid. |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |